Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR) entered into a definitive agreement with AstraZeneca (NYSE: AZN) to acquire Myalept, an orphan product ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE